Novavax (NVAX) on Monday announced an agreement in principle to supply up to 76 million doses of its coronavirus vaccine candidate to Canada. The news sent NVAX stock surging early before shares pulled back.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,